Episode Details
Back to Episodes
Pharmaceutical Executive Daily: FDA Plans to Remove Two Study Requirement for New Drug Approvals
Published 3 months ago
Description
In today’s Pharmaceutical Executive Daily, the FDA reportedly removes its two-study requirement for new drug approvals, Hims & Hers enters a $1 billion agreement to acquire Eucalyptus, and experts examine how FDA can help ease early-stage clinical trial bottlenecks.